Stay updated on TKI in Myeloid Hypereosinophilic Syndrome Clinical Trial
Sign up to get notified when there's something new on the TKI in Myeloid Hypereosinophilic Syndrome Clinical Trial page.

Latest updates to the TKI in Myeloid Hypereosinophilic Syndrome Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedRevision labels updated from v3.4.3 to v3.5.0, reflecting an update to the site's versioning information.SummaryDifference0.1%

- Check19 days agoChange DetectedThe study record includes a newly updated timestamp and revised completion dates (primary completion and study completion). Some previously listed dates were adjusted or removed to reflect current timelines.SummaryDifference0.4%

- Check26 days agoChange DetectedStudy status updated to Active, not recruiting and enrollment updated to 70. Study team contact details were removed, and the page revision is v3.4.3.SummaryDifference2%

- Check55 days agoChange DetectedA new revision tag 'Revision: v3.4.2' is now shown. The prior lapse-in-government-funding notice and 'Revision: v3.4.1' have been removed.SummaryDifference0.4%

- Check62 days agoChange DetectedThe page now includes a site-wide notice about a lapse in government funding and that the NIH Clinical Center remains open, with a link to opm.gov; a new Revision: v3.4.1 was added to replace Revision: v3.4.0.SummaryDifference0.4%

- Check69 days agoChange DetectedEnrollment (Estimated) increased from 60 to 80, and Primary Completion (Estimated) and Study Completion (Estimated) dates were updated to 2026-03-10. Show glossary was added and the page revision was updated to v3.4.0.SummaryDifference0.7%

Stay in the know with updates to TKI in Myeloid Hypereosinophilic Syndrome Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TKI in Myeloid Hypereosinophilic Syndrome Clinical Trial page.